Diamyd Medical − Working towards a cure for Diabetes

Diamyd develops pharmaceuticals for the treatment of autoimmune diabetes and its complications. Our vision is to one day be able to prevent and cure the autoimmune form of diabetes. Diamyd's lead product, the diabetes vaccine Diamyd® has shown to significantly slow down the disease process.

Diabetes − a chronic disease
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, resulting in considerable suffering and extensive costs for society.

US Trial with the Diamyd® vaccine

Diamyd Medical is currently conducting a Phase III clinical trial in patients recently diagnosed with type 1 diabetes in the USA - the DiaPrevent research study.